Page 15 - SaxoCell Annual Report 2021

University of Leipzig

Founded in 1409, Leipzig University is one of the oldest universities in Europe. It is a
cosmopolitan, modern comprehensive university with 14 faculties, 465 professorships and over
31,000 students. Today, as a member of the German U15 association, the University of Leipzig is
one of Germany's major universities with strong research and medical leadership. The research
strength of the University of Leipzig is reflected in a DFG Research Center, five DFG Collaborative
Research Centers, two Humboldt Professorships and six ERC Grants. At the same time, it is one
of the universities in Germany with the highest number of start-ups (Top five in the category
"Start-ups with knowledge transfer from the university"). The university is a member of the Leipzig
Science Network, which deepens cooperation with universities and non-university research SaxoCell Core Institutions
institutions and increases the national and international visibility of Leipzig as a science location.
The university's research fields form the interface for intensive cooperation with other scientific
institutions in Leipzig, including three Max Planck Institutes, two Fraunhofer Institutes, four
Leibniz Institutes, two Helmholtz Centers, a federally funded integrated research and treatment
center, and a high-performance University Hospital.

At the University Hospital, the Department of Cell Therapy is well established, providing promising
and innovative treatment strategies (stem cells, CAR-T cells) for patients with diseases of the
hematopoietic system in collaboration with the Institute of Clinical Immunology and the
Fraunhofer IZI. Furthermore, the Early Clinical Trials Unit Leipzig (ECTUL) for innovative tumor
therapy and therapies of other disciplines – a Phase-I-Unit, serves to catalyze translational
research and the development of new drugs and treatment approaches under optimized
conditions.

10